IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Codexis, Purolite collaborate to develop immobilized enzymes for pharmaceutical market

3:00 AM MDT | July 17, 2013 | Deepti Ramesh

Codexis (Redwood City, CA), a company that engineers enzymes for pharmaceutical, biofuel, and chemical productions, says it has entered into a collaboration with Purolite (Bala Cynwyd, PA), to develop and market immobilized enzymes for the pharmaceutical industry. Purolite is a leading manufacturer of ion exchange, catalyst, adsorbent, and specialty resins, Codexis says. Enzymes are immobilized by binding to inert resins, allowing for the easier separation from a reaction mixture; and immobilization often allows for the use of these enzymes under different...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa